Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 02/28/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of a stylized letter "S" made up of curved lines and circles.
PIXEL COUNT ACCEPTABLE
YES
PIXEL COUNT
400 x 331
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Strateos, Inc.
*MAILING ADDRESS
3565 Haven Avenue, Suite 3
*CITY
Menlo Park
*STATE
(Required for U.S. applicants)
California
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
94025
*EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION
Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
042
*IDENTIFICATION
Software as a service ("SAAS") featuring access to remote and on-demand automated cloud labs accessible from a web browser that enable users
around the world to easily access and control drug discovery, cell and gene therapy and synthetic biology workflows; Workflows for designing laboratory experiments, for running laboratory
experiments, generating data, for reviewing and analyzing laboratory and environmental data, and experiment results; Provide support to the pharmaceutical, biotechnology, healthcare, synthetic
biology, agscience and medical device industries in the form of research services, biopharmaceutical development, biologic assay development, commercialization, preclinical research, clinical
research, and pharmacovigilance; software as a service ("SAAS") enabling organizations to control their own scientific instruments and facilities locally and worldwide, schedule workflows and manage
their scientific data. software as a service ("SAAS") featuring software for running computer simulations of laboratory experiments, for running computer simulations of biological and chemical
phenomena and systems, for optimizing laboratory experiment parameters with computational methods, and for comparison of computer simulations against empirically observed laboratory experiment
results; software as a service ("SAAS") featuring software for research and development of chemicals, pharmaceuticals, biologics, and vaccines, and cell and gene therapies; software as a service
("SAAS") for providing regulatory compliance documentation following experiments, for performing regulatory agencies audits following experiments, and for performing internal audits following
experiments; conducting laboratory experiments on behalf of others; scientific testing of chemicals, pharmaceuticals, biologics, vaccines, and cell and gene therapies; toxicological testing services
for pharmaceuticals, chemicals, biologics, vaccines, and cell and gene therapies; biopharmaceutical and synthetic biology research design and scientific testing services; custom assay development for
chemicals, pharmaceuticals, biologics, vaccines, and cell and gene therapies; technological consultancy in the field of information technology; technological consultancy in the field of life
sciences, drug discovery, synthetic biology software engineering, hardware engineering and laboratory automation
Approved for use through 02/28/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:90623925
Filing Date:04/05/2021
To the Commissioner for Trademarks:
MARK: S (stylized and/or with design, see mark)
The literal element of the mark consists of S. The mark consists of a stylized letter "S" made up of curved lines and circles.
The applicant, Strateos, Inc., a corporation of Delaware, having an address of
3565 Haven Avenue, Suite 3
Menlo Park, California 94025
United States
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 042: Software as a service ("SAAS") featuring access to remote and on-demand automated cloud labs accessible from a web browser that enable users around the world to easily
access and control drug discovery, cell and gene therapy and synthetic biology workflows; Workflows for designing laboratory experiments, for running laboratory experiments, generating data, for
reviewing and analyzing laboratory and environmental data, and experiment results; Provide support to the pharmaceutical, biotechnology, healthcare, synthetic biology, agscience and medical device
industries in the form of research services, biopharmaceutical development, biologic assay development, commercialization, preclinical research, clinical research, and pharmacovigilance; software as
a service ("SAAS") enabling organizations to control their own scientific instruments and facilities locally and worldwide, schedule workflows and manage their scientific data. software as a service
("SAAS") featuring software for running computer simulations of laboratory experiments, for running computer simulations of biological and chemical phenomena and systems, for optimizing laboratory
experiment parameters with computational methods, and for comparison of computer simulations against empirically observed laboratory experiment results; software as a service ("SAAS") featuring
software for research and development of chemicals, pharmaceuticals, biologics, and vaccines, and cell and gene therapies; software as a service ("SAAS") for providing regulatory compliance
documentation following experiments, for performing regulatory agencies audits following experiments, and for performing internal audits following experiments; conducting laboratory experiments on
behalf of others; scientific testing of chemicals, pharmaceuticals, biologics, vaccines, and cell and gene therapies; toxicological testing services for pharmaceuticals, chemicals, biologics,
vaccines, and cell and gene therapies; biopharmaceutical and synthetic biology research design and scientific testing services; custom assay development for chemicals, pharmaceuticals, biologics,
vaccines, and cell and gene therapies; technological consultancy in the field of information technology; technological consultancy in the field of life sciences, drug discovery, synthetic biology
software engineering, hardware engineering and laboratory automation
In International Class 042, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 09/23/2019, and first used in
commerce at least as early as 09/23/2019, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any
item in the class of listed goods/services, consisting of a(n) screenshots from website.
The owner's/holder's proposed attorney information: Stacey J. Watson, Esq.. Other appointed attorneys are Katrina G. Hull, Jacqueline L. Patt. Stacey J. Watson, Esq. of Markery Law LLC, is a
member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
P.O. Box 84150
Gaithersburg, Maryland 20883-4150
United States
202-888-7786(phone)
(202) 803-7953(fax)
docket@markerylaw.com
The docket/reference number is US-STR-002A.
Stacey J. Watson, Esq. submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any
U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $350 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: //Marc Siladi// Date: 04/02/2021
Signatory's Name: Marc Siladi
Signatory's Position: Senior Director of Marketing
Signatory's Phone Number: Not Provided
Signature method: Sent to third party for signature
Payment Sale Number: 90623925
Payment Accounting Date: 04/05/2021
Serial Number: 90623925
Internet Transmission Date: Mon Apr 05 14:33:34 ET 2021
TEAS Stamp: USPTO/BAS-XXXX:XXXX:XXXX:XXXX:XXXX:XXXX:
XXXX:XXXX-20210405143334487048-90623925-
770f250bfb326adaca8fe4b381816542efca96d9
3b4981cca48b5d9fc8aeec8c-CC-33334650-202
10402112941585858